1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Crump, M.P. Elisseeva, E. Gong, J.-H. Clark-Lewis, I. Sykes, B.D. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking NE FEBS Lett. FEBLAL 0165 0014-5793 489 171 10.1016/S0014-5793(00)02393-0 11165244 Structure/Function of Human Herpesvirus-8 Mip-II (1-71) and the Antagonist N-Terminal Segment (1-10) 2001 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 8142.661 VIRAL MACROPHAGE INFLAMMATORY PROTEIN-II RESIDUES 1-71 1 syn polymer VMIP-II, VMIP-1B no no LGASWHRPDKCCLGYQKRPLPQVLLSSWYPTSQLCSKPGVIFLTKRGRQVCADKSKDWVKKLMQQLPVTAR LGASWHRPDKCCLGYQKRPLPQVLLSSWYPTSQLCSKPGVIFLTKRGRQVCADKSKDWVKKLMQQLPVTAR A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n repository Initial release Version format compliance Version format compliance 1 0 2001-01-07 1 1 2011-05-08 1 2 2011-07-13 NMR SOLUTION STRUCTURES OF THE VMIP-II 1-10 PEPTIDE FROM KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS. (RESIDUES 1-10 55 STRUCTURES) CRYSTAL STRUCTURE OF VIRAL MACROPHAGE INFLAMMATORY PROTEIN-II STRUCTURE OF THE ANTI-HIV CHEMOKINE VMIP-II PDBE Y PDBE 2000-12-01 REL 37296 HUMAN HERPESVIRUS 8 sample SEE PAPER FOR FURTHER EXPERIMENTAL DETAILS. 1 1 DQF-COSY TOCSY NOESY 5.0 pH 1 atm 303 K REFINEMENT DETAILS CAN BE FOUND IN THE JOURNAL CITATION. simulated annealing BRUNGER refinement X-PLOR structure solution X-PLOR 600 Varian UNITY LEU 1 n 1 LEU 1 A GLY 2 n 2 GLY 2 A ALA 3 n 3 ALA 3 A SER 4 n 4 SER 4 A TRP 5 n 5 TRP 5 A HIS 6 n 6 HIS 6 A ARG 7 n 7 ARG 7 A PRO 8 n 8 PRO 8 A ASP 9 n 9 ASP 9 A LYS 10 n 10 LYS 10 A CYS 11 n 11 CYS 11 A CYS 12 n 12 CYS 12 A LEU 13 n 13 LEU 13 A GLY 14 n 14 GLY 14 A TYR 15 n 15 TYR 15 A GLN 16 n 16 GLN 16 A LYS 17 n 17 LYS 17 A ARG 18 n 18 ARG 18 A PRO 19 n 19 PRO 19 A LEU 20 n 20 LEU 20 A PRO 21 n 21 PRO 21 A GLN 22 n 22 GLN 22 A VAL 23 n 23 VAL 23 A LEU 24 n 24 LEU 24 A LEU 25 n 25 LEU 25 A SER 26 n 26 SER 26 A SER 27 n 27 SER 27 A TRP 28 n 28 TRP 28 A TYR 29 n 29 TYR 29 A PRO 30 n 30 PRO 30 A THR 31 n 31 THR 31 A SER 32 n 32 SER 32 A GLN 33 n 33 GLN 33 A LEU 34 n 34 LEU 34 A CYS 35 n 35 CYS 35 A SER 36 n 36 SER 36 A LYS 37 n 37 LYS 37 A PRO 38 n 38 PRO 38 A GLY 39 n 39 GLY 39 A VAL 40 n 40 VAL 40 A ILE 41 n 41 ILE 41 A PHE 42 n 42 PHE 42 A LEU 43 n 43 LEU 43 A THR 44 n 44 THR 44 A LYS 45 n 45 LYS 45 A ARG 46 n 46 ARG 46 A GLY 47 n 47 GLY 47 A ARG 48 n 48 ARG 48 A GLN 49 n 49 GLN 49 A VAL 50 n 50 VAL 50 A CYS 51 n 51 CYS 51 A ALA 52 n 52 ALA 52 A ASP 53 n 53 ASP 53 A LYS 54 n 54 LYS 54 A SER 55 n 55 SER 55 A LYS 56 n 56 LYS 56 A ASP 57 n 57 ASP 57 A TRP 58 n 58 TRP 58 A VAL 59 n 59 VAL 59 A LYS 60 n 60 LYS 60 A LYS 61 n 61 LYS 61 A LEU 62 n 62 LEU 62 A MET 63 n 63 MET 63 A GLN 64 n 64 GLN 64 A GLN 65 n 65 GLN 65 A LEU 66 n 66 LEU 66 A PRO 67 n 67 PRO 67 A VAL 68 n 68 VAL 68 A THR 69 n 69 THR 69 A ALA 70 n 70 ALA 70 A ARG 71 n 71 ARG 71 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O SER 27 A O SER 27 A N LEU 43 A N LEU 43 A O VAL 40 A O VAL 40 A N ALA 52 A N ALA 52 1 A A O H LEU LEU 62 66 1.54 1 A A O H PRO LYS 8 10 1.56 1 A ASP 9 -66.50 61.37 1 A CYS 12 -38.06 120.68 1 A LYS 17 87.42 -16.58 1 A SER 26 -115.48 -71.79 1 A SER 27 -147.62 -158.91 1 A LEU 34 -88.07 46.61 1 A LYS 37 -170.05 71.99 1 A LYS 56 -52.42 -169.23 1 A PRO 67 -80.01 -91.59 1 A VAL 68 172.18 144.30 VIRAL MACROPHAGE INFLAMMATORY PROTEIN-II MINIMIZED AVERAGE NMR solution structure of vMIP-II 1-71 from Kaposi's sarcoma-associated herpesvirus (minimized average structure). 1 N N A ALA 3 A ALA 3 HELX_P A ARG 7 A ARG 7 5 1 5 A ASP 57 A ASP 57 HELX_P A LEU 66 A LEU 66 1 2 10 disulf 2.020 A CYS 11 A SG CYS 11 1_555 A CYS 35 A SG CYS 35 1_555 disulf 2.021 A CYS 12 A SG CYS 12 1_555 A CYS 51 A SG CYS 51 1_555 CHEMOKINE CHEMOKINE, CXCR4, ANATAGONIST, VMIP-II VMI2_KSHV UNP 1 Q98157 24 94 1HFG 1 71 Q98157 A 1 1 71 3 anti-parallel anti-parallel A SER 27 A SER 27 A PRO 30 A PRO 30 A VAL 40 A VAL 40 A LEU 43 A LEU 43 A GLN 49 A GLN 49 A ALA 52 A ALA 52 1 P 1